These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors. Grant KG; Krisky DM; Ataai MM; Glorioso JC Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174 [TBL] [Abstract][Full Text] [Related]
3. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Krisky DM; Wolfe D; Goins WF; Marconi PC; Ramakrishnan R; Mata M; Rouse RJ; Fink DJ; Glorioso JC Gene Ther; 1998 Dec; 5(12):1593-603. PubMed ID: 10023438 [TBL] [Abstract][Full Text] [Related]
4. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector. Yao F; Theopold C; Hoeller D; Bleiziffer O; Lu Z Mol Ther; 2006 Jun; 13(6):1133-41. PubMed ID: 16574491 [TBL] [Abstract][Full Text] [Related]
5. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection. Rivera-Gonzalez R; Imbalzano AN; Gu B; Deluca NA Virology; 1994 Aug; 202(2):550-64. PubMed ID: 8030221 [TBL] [Abstract][Full Text] [Related]
6. Characterization of regulatory functions of the HSV-1 immediate-early protein ICP22. Prod'hon C; Machuca I; Berthomme H; Epstein A; Jacquemont B Virology; 1996 Dec; 226(2):393-402. PubMed ID: 8955059 [TBL] [Abstract][Full Text] [Related]
7. Intracellular localization of the herpes simplex virus type 1 major transcriptional regulatory protein, ICP4, is affected by ICP27. Zhu Z; Schaffer PA J Virol; 1995 Jan; 69(1):49-59. PubMed ID: 7983745 [TBL] [Abstract][Full Text] [Related]
8. An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells. Lee CY; Bu LX; Rennie PS; Jia WW Cancer Gene Ther; 2007 Jul; 14(7):652-60. PubMed ID: 17479106 [TBL] [Abstract][Full Text] [Related]
9. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas. Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566 [TBL] [Abstract][Full Text] [Related]
10. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239 [TBL] [Abstract][Full Text] [Related]
11. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons. Müller L; Saydam O; Saeki Y; Heid I; Fraefel C J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700 [TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells. Jean S; LeVan KM; Song B; Levine M; Knipe DM Virology; 2001 May; 283(2):273-84. PubMed ID: 11336552 [TBL] [Abstract][Full Text] [Related]
13. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors. Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453 [TBL] [Abstract][Full Text] [Related]
14. Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. Zhu Z; Cai W; Schaffer PA J Virol; 1994 May; 68(5):3027-40. PubMed ID: 8151771 [TBL] [Abstract][Full Text] [Related]
15. High efficiency transient expression of eukaryotic genes: use of an HSV-1 immediate early promoter (ICP4). Liu X; Giza CC; Vrana KE Biotechniques; 1990 Aug; 9(2):168-73. PubMed ID: 2169263 [TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus ICP27 is required for virus-induced stabilization of the ARE-containing IEX-1 mRNA encoded by the human IER3 gene. Corcoran JA; Hsu WL; Smiley JR J Virol; 2006 Oct; 80(19):9720-9. PubMed ID: 16973576 [TBL] [Abstract][Full Text] [Related]
17. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583 [TBL] [Abstract][Full Text] [Related]
18. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals. Berthomme H; Fournel S; Epstein AL Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275 [TBL] [Abstract][Full Text] [Related]
19. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922 [TBL] [Abstract][Full Text] [Related]
20. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. Halford WP; Kemp CD; Isler JA; Davido DJ; Schaffer PA J Virol; 2001 Jul; 75(13):6143-53. PubMed ID: 11390616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]